Hogan Lovells
Table des matières
- New Belgian legislation on the distribution of medical devices
- Belgian sunshine rules – Submissions required by 31 May 2018 at the latest
- The new Belgian Biobank legislation will apply on 1 November 2018: are you ready?
- Belgian Competition Authority adopts guidelines on exchanges of information in the context of trade associations
- The Belgian Data Protection Authority Publishes Recommendation Concerning Data Processing for Direct Marketing Purposes
- Belgian AFMPS latest guidance in the context of COVID-19 outbreak
- Belgium temporarily bans the making available and use of rapid COVID-19 IVD self-tests
- The AFMPS issues decision regarding urgent measures to fight shortage of medicines due to COVID-19
- Belgium follows the FDA's approach on the reprocessing of surgical masks and FFP2/FFP3 facemasks
- COVID-19- AFMPS reviews its export ban on certain medicinal products outside the EEA
- MDCG guidance on notified body audits in the context of COVID-19 restriction measures
- The Belgian AFMPS warns about risk of hemolysis associated with the use of hydroxychloroquine
- Belgian AFMPS abolishes quota previously imposed on paracetamol-based medicines
- AFMPS issues Circular allowing hospitals to reprocess single-use devices
- The AFMPS issues third version of the Alternative Test Protocol for surgical face masks
- The AFMPS further extends measures to combat shortages of medicinal products by another month
- Abuse by non-dominant companies? Belgian rules prohibiting "abuses of economic dependence" now enforceable
- Belgian DPA Issues Guidance on Temperature Measurements in the Context of COVID-19
- MDCG guidance for consultations of authorities on devices incorporating a medicinal product
- Belgian Data Protection Authority publishes guidance concerning Schrems II